MARKET

FLGT

FLGT

Fulgent Genetics
NASDAQ
20.36
+0.25
+1.24%
After Hours: 20.36 0 0.00% 16:03 04/19 EDT
OPEN
20.01
PREV CLOSE
20.11
HIGH
20.37
LOW
20.01
VOLUME
156.23K
TURNOVER
0
52 WEEK HIGH
44.09
52 WEEK LOW
19.88
MARKET CAP
608.78M
P/E (TTM)
-3.6133
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at FLGT last week (0408-0412)?
Weekly Report · 6d ago
Press Release: Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024. Management will host a conference call for the investment community the same day. Fulgent is a technology-based company with a well-established laboratory services business and a therapeutic development business. The company will release its first quarter 2024 financial results before the market opens.
Dow Jones · 04/11 20:10
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
Fulgent Genetics, Inc. Will release its first quarter 2024 financial results before the market opens on Friday, May 3, 2024. Management will host a conference call for the investment community the same day to discuss the results. Fulgent is a technology-based company with a well-established laboratory services business and a therapeutic development business.
Barchart · 04/11 15:05
Weekly Report: what happened at FLGT last week (0401-0405)?
Weekly Report · 04/08 10:49
Weekly Report: what happened at FLGT last week (0325-0329)?
Weekly Report · 04/01 10:47
Fulgent Genetics: Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Press release · 03/28 00:24
Weekly Report: what happened at FLGT last week (0318-0322)?
Weekly Report · 03/25 10:49
Weekly Report: what happened at FLGT last week (0311-0315)?
Weekly Report · 03/18 10:48
More
About FLGT
Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.

Webull offers Fulgent Genetics Inc stock information, including NASDAQ: FLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLGT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FLGT stock methods without spending real money on the virtual paper trading platform.